Concepedia

Sequential intravesical gemcitabine-docetaxel vs. bacillus Calmette-Guerin (BCG) in the treatment of non-muscle invasive bladder cancer: A preliminary cost-effectiveness analysis

Laura Bukavina, Spencer Bell, Vignesh T. Packiam, Marc C. Smaldone, Philip H. Abbosh, Robert G. Uzzo, Alexander Kutikov, Andres Correa, Diana Magee

Urologic Oncology Seminars and Original Investigations · 2023 · 12 citations · 3 references

DOI

Concepts

References

3

Treatment of High-grade Non–muscle-invasive Bladder Carcinoma by Standard Number and Dose of BCG Instillations Versus Reduced Number and Standard Dose of BCG Instillations: Results of the European Association of Urology Research Foundation Randomised Phase III Clinical Trial “NIMBUS”

Marc‐Oliver Grimm, Antoine G. van der Heijden, Marc Colombel et al. · European Urology · 2020 · 133 citations

, , +8

The Half-Cycle Correction Explained: Two Alternative Pedagogical Approaches

David Naimark, Michelle Bott, Murray Krahn · Medical Decision Making · 2008 · 94 citations

, , +12

Sequential Intravesical Gemcitabine and Docetaxel for bacillus Calmette-Guérin-Naïve High-Risk Nonmuscle-Invasive Bladder Cancer

Ian M. McElree, Ryan L. Steinberg, Alex C. Martin et al. · The Journal of Urology · 2022 · 70 citations

, , +11